Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

4.63

-0.08 (-1.70%)

At close: May 02, 2025, 3:59 PM

4.95

6.91%

After-hours: May 02, 2025, 04:14 PM EDT

Lexeo Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-98.33M	-66.39M	-59.28M	-50.62M	-5.15M
Depreciation & Amortization	2M	1.84M	1.15M	13.4K	n/a
Stock-Based Compensation	12.47M	3.04M	1.78M	386K	n/a
Other Working Capital	351K	1.66M	2.22M	3.03M	105.83K
Other Non-Cash Items	-23K	530K	n/a	-692	1.87M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.73M	1.48M	1.79M	6.04M	150.15K
Operating Cash Flow	-81.15M	-59.5M	-54.56M	-44.18M	-3.13M
Capital Expenditures	-481K	-165K	-901K	-188K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-93.6M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-50K	-229K	n/a	n/a
Investing Cash Flow	-94.08M	-165K	-901K	-188K	n/a
Debt Repayment	-410K	3.58M	-163K	n/a	2.6M
Common Stock Repurchased	-17K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	491K	-35K	332K	-203K	-223.59K
Financial Cash Flow	88.78M	103.79M	189K	150.86M	32.38M
Net Cash Flow	-86.45M	44.13M	-55.27M	106.49M	29.25M
Free Cash Flow	-81.63M	-59.66M	-55.46M	-44.37M	-3.13M